Free Trial

Recursion Pharmaceuticals (RXRX) SEC Filings & 10K Form

Recursion Pharmaceuticals logo
$6.04 -0.23 (-3.67%)
(As of 11/20/2024 ET)

Recent Recursion Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/19/2024
5:26 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:26 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:26 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2024
5:26 PM
Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
5:52 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:19 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:19 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
3:34 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
9:11 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
8:22 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
3:57 PM
Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
1:48 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
9:34 AM
FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
3:18 PM
Recursion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
5:05 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
5:12 AM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
11/04/2024
3:16 PM
Kinnevik AB (0001766574) (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
11/04/2024
12:27 PM
Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
8:46 AM
BAILLIE GIFFORD & CO (Filed by)
Recursion Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
10/31/2024
5:01 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
4:20 PM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
10/29/2024
3:35 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
4:25 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
3:22 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
10/18/2024
9:59 AM
Recursion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/17/2024
4:27 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
4:15 PM
Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
3:42 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
5:40 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
5:00 AM
Recursion Pharmaceuticals (Filer)
Form DEFM14A
10/09/2024
3:23 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
3:19 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
5:29 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
5:30 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
5:30 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2024
5:30 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:58 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
9:27 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
12:31 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

10/02/2024
7:03 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
1:20 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
5:15 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2024
3:14 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/19/2024
4:48 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:27 PM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
09/17/2024
5:03 AM
Recursion Pharmaceuticals (Filer)
Form PREM14A
09/12/2024
5:28 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
4:15 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
4:00 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/06/2024
3:57 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
4:25 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:43 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
4:24 PM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
09/04/2024
12:16 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:48 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:27 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
7:01 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
7:02 AM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
08/30/2024
3:26 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
3:53 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
3:49 PM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
08/27/2024
3:10 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:42 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
4:25 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
5:48 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:25 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
6:09 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:09 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:09 PM
Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:09 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:24 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:35 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
3:22 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:19 PM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
08/08/2024
4:23 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
11:56 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2024
7:05 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:09 AM
Recursion Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
7:10 AM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
08/07/2024
12:34 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:50 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2024
5:16 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
5:15 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2024
3:37 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:17 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/12/2024
5:52 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4/A
07/12/2024
5:54 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:51 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:51 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

07/11/2024
9:38 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
3:41 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
11:56 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:30 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:25 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/08/2024
3:17 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G
07/03/2024
3:39 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
3:39 PM
Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
3:39 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RXRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners